Ticker
    ADIL

    Price
    3.54
    Stock movement up
    +0.07 (2.02%)
    Company name
    Adial Pharmaceuticals Inc
    Exchange
    (NASDAQ
    ,
    Currency
    USD
    )
    Sector
    Healthcare >
    Biotechnology
    Markedsverdi
    4.04M
    Ent verdi
    617.92K
    Pris/omsetning
    -
    Pris/bok
    0.75
    Utbytte avkastning
    -
    Utbytte vekst
    -
    Vekst år
    -
    FCF-utbetaling
    -
    Etterfølgende P/E
    -
    Fremtidig P/E
    -
    PEG
    -
    EPS-vekst
    -
    1 års avkastning
    -71.68%
    3 års avkastning
    -52.24%
    5 års avkastning
    -45.33%
    10 års avkastning
    -
    Sist oppdatert: 2023-09-08
    Adial Pharmaceuticals regains Nasdaq compliance
    Get the latest news and real-time alerts from Adial Pharmaceuticals, Inc. (ADIL) stock at Seeking Alpha.
    23. august 2023

    iO Charts is a Seeking Alpha partner

    Adial Pharmaceuticals reports Q2 results
    Get the latest news and real-time alerts from Adial Pharmaceuticals, Inc. (ADIL) stock at Seeking Alpha.
    22. august 2023

    iO Charts is a Seeking Alpha partner

    UTBYTTE

    ADIL betaler ikke utbytte
    Adial Pharmaceuticals reports Q2 results
    Get the latest news and real-time alerts from Adial Pharmaceuticals, Inc. (ADIL) stock at Seeking Alpha.
    21. august 2023

    iO Charts is a Seeking Alpha partner

    Adial Pharmaceuticals announces reverse stock split to regain compliance
    Get the latest news and real-time alerts from Adial Pharmaceuticals, Inc. (ADIL) stock at Seeking Alpha.
    4. august 2023

    iO Charts is a Seeking Alpha partner

    VERDSETTELSE

    Verdsettelsesforhold

    Verdsettelsesforhold-data
    Etterfølgende P/E-
    Pris til OCF-
    Pris til FCF-
    Pris til EBITDA-
    EV i forhold til EBITDA-

    Verdsettelse (Salg/Bokført verdi)

    Verdsettelse (Salg/Bokført verdi) data
    Pris til omsetning-
    Pris til bok0.75
    EV i forhold til salg-
    Adial Pharmaceuticals reports FY results
    Get the latest news and real-time alerts from Adial Pharmaceuticals, Inc. (ADIL) stock at Seeking Alpha.
    31. mars 2023

    iO Charts is a Seeking Alpha partner

    Adial soars 63% after regulatory update on lead asset
    Get the latest news and real-time alerts from Adial Pharmaceuticals, Inc. (ADIL) stock at Seeking Alpha.
    7. mars 2023

    iO Charts is a Seeking Alpha partner

    ØKONOMI

    Per aksje

    Per aksje-data
    Gjeldende aksje antall1.14M
    EPS (TTM)-15.25
    FCF per aksje (TTM)-11.47

    Resultatregnskap

    Resultatregnskap-data
    Inntekter (TTM)0.00
    Bruttofortjeneste (TTM)0.00
    Driftsinntekter (TTM)-16.06M
    Netto inntekt (TTM)-15.70M
    EPS (TTM)-15.25
    EPS (1 år fremover)-15.50

    Marginer

    Marginer-data
    Bruttomargin (TTM)-
    Driftsmargin (TTM)-
    Fortjenestemargin (TTM)-

    Balanse

    Opprett en gratis konto eller logg inn for å få tilgang til dette diagrammet
    Balanse-data
    Kontanter5.75M
    Netto fordringer0.00
    Samlede omløpsmidler6.77M
    Goodwill248.97K
    Immaterielle eiendeler4.62K
    Eiendom, anlegg og utstyr0.00
    Sum eiendeler7.74M
    Leverandørgjeld278.20K
    Kortsiktig/nåværende langsiktig gjeld220.25K
    Sum kortsiktig gjeld1.33M
    Sum gjeld2.33M
    Aksjonærenes egenkapital5.41M
    Netto varige driftsmidler4.70M

    Kontantstrøm

    Opprett en gratis konto eller logg inn for å få tilgang til dette diagrammet
    Kontantstrøm-data
    Kontantstrøm fra drift (TTM)-11.81M
    Kapitalutgifter (TTM)0.00
    Fri kontantstrøm (TTM)-11.81M
    Utbetalt utbytte (TTM)0.00

    Finansielle inntekter

    Opprett en gratis konto eller logg inn for å få tilgang til dette diagrammet
    Finansielle inntekter-data
    Egenkapitalavkastning-290.17%
    Avkastning på eiendeler-202.74%
    Avkastning på investert kapital-287.25%
    Kontantavkastning på investert kapital-216.11%
    Adial Pharmaceuticals prices $0.75M in stock offering
    Get the latest news and real-time alerts from Adial Pharmaceuticals, Inc. (ADIL) stock at Seeking Alpha.
    24. februar 2023

    iO Charts is a Seeking Alpha partner

    Adial Pharmaceuticals GAAP EPS of -$0.12 beats by $0.06
    Get the latest news and real-time alerts from Adial Pharmaceuticals, Inc. (ADIL) stock at Seeking Alpha.
    14. november 2022

    iO Charts is a Seeking Alpha partner

    AKSJEINFORMASJON

    Aksjediagram

    Aksjekurs-data
    Åpning3.46
    Daglig høy3.54
    Daglig lav3.46
    Daglig volum4K
    Tidenes høyeste208.25
    1 år analytikerestimat187.50
    Beta0.98
    EPS (TTM)-15.25
    Utbytte per aksje-
    Ex-div dato-
    Neste dato for resultatpresentasjon13 Nov 2023

    Nedsidepotensial

    Nedsidepotensial-data
    ADILS&P500
    Nåværende prisfall fra toppnotering-98.30%-6.74%
    Høyeste prisfall-98.43%-56.47%
    Dato for høyeste fall17 Aug 20239 Mar 2009
    Gj.snittlig fall fra topp-74.55%-11.49%
    Gj.snittlig tid til ny topp117 days13 days
    Maks tid til ny topp1171 days1805 days
    Adial Pharmaceuticals names new executive chief
    Get the latest news and real-time alerts from Adial Pharmaceuticals, Inc. (ADIL) stock at Seeking Alpha.
    22. august 2022

    iO Charts is a Seeking Alpha partner

    Adial Clinical Trial: A Fluff Or A Win?
    Onward Phase III Clinical Trial of Adial Pharmaceutical’s AD04, a treatment for Alcohol Abuse Disorder, was completed in early 2022. Read about the stock outlook here.
    22. august 2022

    iO Charts is a Seeking Alpha partner

    SELSKAPSOPPLYSNINGER
    ADIL (Adial Pharmaceuticals Inc) company logo
    Markedsverdi
    4.04M
    Markedsverdi kategori
    Small-cap
    Beskrivelse
    Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a selective serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Charlottesville, Virginia.
    Ansatte
    16
    Nettsted
    https://www.adialpharma.com
    Investorrelasjoner
    -
    SEC-innsendelser
    ADIL SEC filings
    Adm. direktør
    William B. Stilley
    Land
    USA
    By
    Charlottesville
    Aksjetype
    Common stock
    CCC-status
    -
    Utbyttefrekvens
    -
    ARRANGEMENTER OG PRESENTASJONER
    ArrangementerPresentasjoner
    Adial gets cut at Maxim on need for capital to map path for alcohol disorder drug
    Get the latest news and real-time alerts from Adial Pharmaceuticals, Inc. (ADIL) stock at Seeking Alpha.
    17. august 2022

    iO Charts is a Seeking Alpha partner

    Adial Pharmaceuticals GAAP EPS of -$0.16 beats by $0.01
    Get the latest news and real-time alerts from Adial Pharmaceuticals, Inc. (ADIL) stock at Seeking Alpha.
    16. august 2022

    iO Charts is a Seeking Alpha partner

    FORSTÅ VIRKSOMHETEN
    NYHETER OM SELSKAPET
    Seeking AlphaPressemeldinger
    Adial stock slumps 25% as AD04 fails to best placebo in very heavy drinkers in trial
    Get the latest news and real-time alerts from Adial Pharmaceuticals, Inc. (ADIL) stock at Seeking Alpha.
    20. juli 2022
    Adial gets US patent linked to AD04, diagnostic test for alcohol/opioid use disorder
    Get the latest news and real-time alerts from Adial Pharmaceuticals, Inc. (ADIL) stock at Seeking Alpha.
    14. juni 2022
    Adial Pharmaceuticals GAAP EPS of -$0.13 beats by $0.04
    Get the latest news and real-time alerts from Adial Pharmaceuticals, Inc. (ADIL) stock at Seeking Alpha.
    16. mai 2022
    Adial Pharmaceuticals reports Q1 results
    Get the latest news and real-time alerts from Adial Pharmaceuticals, Inc. (ADIL) stock at Seeking Alpha.
    16. mai 2022
    Adial Pharmaceuticals announces $10M registered direct offering
    Get the latest news and real-time alerts from Adial Pharmaceuticals, Inc. (ADIL) stock at Seeking Alpha.
    11. februar 2022
    Adial Pharma secures new U.S. patent for AD04 for treatment of opioid use disorder
    Get the latest news and real-time alerts from Adial Pharmaceuticals, Inc. (ADIL) stock at Seeking Alpha.
    24. januar 2022
    Purnovate picks PNV-5030 as lead compound for pain treatment program
    Get the latest news and real-time alerts from Adial Pharmaceuticals, Inc. (ADIL) stock at Seeking Alpha.
    21. oktober 2021
    Adial Pharmaceuticals inks research collaboration agreement with University of Virginia
    Get the latest news and real-time alerts from Adial Pharmaceuticals, Inc. (ADIL) stock at Seeking Alpha.
    28. september 2021
    Adial Pharma reaches enrollment goal in late-stage trial for alcohol use disorder
    Get the latest news and real-time alerts from Adial Pharmaceuticals, Inc. (ADIL) stock at Seeking Alpha.
    20. august 2021
    Adial Pharmaceuticals awarded U.S. and international patents for AD04
    Get the latest news and real-time alerts from Adial Pharmaceuticals, Inc. (ADIL) stock at Seeking Alpha.
    10. august 2021
    iO Charts is a Seeking Alpha partnerNeste side
    Sosialt
    Meny
    Hjem
    Porteføljeadministrasjon
    Selskapsoversikt
    Grønne investeringer (EN)
    Kontakt kundeservice
    Språk EN | HU | NO | SE | DK | FI | ES | DE | NL | FR | IT | PT | PL | CZ | SK | RO | GR | TR | RU | AF
    Ansvarsfraskrivelse
    iO Charts påtar seg intet ansvar eller eventuelt erstatningsansvar for eventuelle feil eller mangler i innholdet på dette nettstedet. Informasjonen på dette nettstedet er gitt på en «som den er»-basis uten garantier for fullstendighet, nøyaktighet, nytte eller aktualitet. Vær også oppmerksom, at enhver handling du basert på informasjonen på dette nettstedet er helt på egen risiko. Dette nettstedet er ment å brukes og må kun brukes til informasjonsformål. Du bør få uavhengig økonomisk rådgivning fra en profesjonell fagperson og uavhengig undersøke og bekrefte alt du ser på nettstedet.
    © 2021 iO Charts Alle rettigheter forbeholdt